Literature DB >> 27639317

Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.

Prabhani U Atukorale1, Gil Covarrubias2, Lisa Bauer3, Efstathios Karathanasis4.   

Abstract

This review seeks to highlight the enormous potential of targeted nanoparticles for molecular imaging applications. Being the closest point-of-contact, circulating nanoparticles can gain direct access to targetable molecular markers of disease that appear on the endothelium. Further, nanoparticles are ideally suitable to vascular targeting due to geometrically enhanced multivalent attachment on the vascular target. This natural synergy between nanoparticles, vascular targeting and molecular imaging can provide new avenues for diagnosis and prognosis of disease with quantitative precision. In addition to the obvious applications of targeting molecular signatures of vascular diseases (e.g., atherosclerosis), deep-tissue diseases often manifest themselves by continuously altering and remodeling their neighboring blood vessels (e.g., cancer). Thus, the remodeled endothelium provides a wide range of targets for nanoparticles and molecular imaging. To demonstrate the potential of molecular imaging, we present a variety of nanoparticles designed for molecular imaging of cancer or atherosclerosis using different imaging modalities.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cancer; Endothelium; MRI; Metastasis; PET; Vascular targeting

Mesh:

Year:  2016        PMID: 27639317      PMCID: PMC5352558          DOI: 10.1016/j.addr.2016.09.006

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  205 in total

Review 1.  Mechanisms of plaque rupture: mechanical and biologic interactions.

Authors:  L H Arroyo; R T Lee
Journal:  Cardiovasc Res       Date:  1999-02       Impact factor: 10.787

2.  Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques.

Authors:  Juan C Frias; Kevin Jon Williams; Edward A Fisher; Zahi A Fayad
Journal:  J Am Chem Soc       Date:  2004-12-22       Impact factor: 15.419

Review 3.  Quantum dots for live cells, in vivo imaging, and diagnostics.

Authors:  X Michalet; F F Pinaud; L A Bentolila; J M Tsay; S Doose; J J Li; G Sundaresan; A M Wu; S S Gambhir; S Weiss
Journal:  Science       Date:  2005-01-28       Impact factor: 47.728

4.  Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.

Authors:  Pubudu M Peiris; Lisa Bauer; Randall Toy; Emily Tran; Jenna Pansky; Elizabeth Doolittle; Erik Schmidt; Elliott Hayden; Aaron Mayer; Ruth A Keri; Mark A Griswold; Efstathios Karathanasis
Journal:  ACS Nano       Date:  2012-04-13       Impact factor: 15.881

Review 5.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

Review 6.  The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect.

Authors:  Hiroshi Maeda
Journal:  Cancer Sci       Date:  2013-04-22       Impact factor: 6.716

7.  Relaxivities of paramagnetic liposomes: on the importance of the chain type and the length of the amphiphilic complex.

Authors:  Sophie Laurent; Luce Vander Elst; Coralie Thirifays; Robert N Muller
Journal:  Eur Biophys J       Date:  2008-04-22       Impact factor: 1.733

8.  Chapter 7. Molecular imaging of tumor vasculature.

Authors:  Weibo Cai; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

9.  New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.

Authors:  Ketan B Ghaghada; Murali Ravoori; Divya Sabapathy; James Bankson; Vikas Kundra; Ananth Annapragada
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

10.  Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.

Authors:  Scott D Swanson; Jolanta F Kukowska-Latallo; Anil K Patri; Chunyan Chen; Song Ge; Zhengyi Cao; Alina Kotlyar; Andrea T East; James R Baker
Journal:  Int J Nanomedicine       Date:  2008
View more
  17 in total

1.  Multimodal assessment of SERS nanoparticle biodistribution post ingestion reveals new potential for clinical translation of Raman imaging.

Authors:  Jos L Campbell; Elliott D SoRelle; Ohad Ilovich; Orly Liba; Michelle L James; Zhen Qiu; Valerie Perez; Carmel T Chan; Adam de la Zerda; Cristina Zavaleta
Journal:  Biomaterials       Date:  2017-04-28       Impact factor: 12.479

Review 2.  Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.

Authors:  Christopher M Hartshorn; Michelle S Bradbury; Gregory M Lanza; Andre E Nel; Jianghong Rao; Andrew Z Wang; Ulrich B Wiesner; Lily Yang; Piotr Grodzinski
Journal:  ACS Nano       Date:  2017-12-22       Impact factor: 15.881

3.  Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity.

Authors:  Shruti P Raghunathan; Vanitha Raguveer; Prabhani U Atukorale; Taylor J Moon; Carolyn Zheng; Peter A Bielecki; Michelle L Wiese; Amy L Goldberg; Gil Covarrubias; Christopher J Hoimes; Efstathios Karathanasis
Journal:  Cancer Res       Date:  2019-08-20       Impact factor: 12.701

4.  Dual agonist immunostimulatory nanoparticles combine with PD1 blockade for curative neoadjuvant immunotherapy of aggressive cancers.

Authors:  Prabhani U Atukorale; Taylor J Moon; Alexandr R Bokatch; Christina F Lusi; Jackson T Routhier; Victoria J Deng; Efstathios Karathanasis
Journal:  Nanoscale       Date:  2022-01-27       Impact factor: 7.790

Review 5.  Nanotheranostics for Image-Guided Cancer Treatment.

Authors:  Isabel S Dennahy; Zheng Han; William M MacCuaig; Hunter M Chalfant; Anna Condacse; Jordan M Hagood; Juan C Claros-Sorto; Wajeeha Razaq; Jennifer Holter-Chakrabarty; Ronald Squires; Barish H Edil; Ajay Jain; Lacey R McNally
Journal:  Pharmaceutics       Date:  2022-04-22       Impact factor: 6.525

6.  Treatment of glioblastoma using multicomponent silica nanoparticles.

Authors:  O Turan; P A Bielecki; V Perera; M Lorkowski; G Covarrubias; K Tong; A Yun; Georgia Loutrianakis; S Raghunathan; Y Park; T Moon; S Cooley; D Dixit; M A Griswold; K B Ghaghada; P M Peiris; J N Rich; E Karathanasis
Journal:  Adv Ther (Weinh)       Date:  2019-09-04

7.  Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications.

Authors:  Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin
Journal:  Adv Funct Mater       Date:  2020-03-03       Impact factor: 18.808

8.  PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma.

Authors:  Gil Covarrubias; Mette L Johansen; Jason Vincent; Bernadette O Erokwu; Sonya E L Craig; Abdelrahman Rahmy; Anthony Cha; Morgan Lorkowski; Christina MacAskill; Bryan Scott; Madhusudhana Gargesha; Debashish Roy; Chris A Flask; Efstathios Karathanasis; Susann M Brady-Kalnay
Journal:  Nanomedicine       Date:  2020-05-13       Impact factor: 5.307

Review 9.  Molecular Imaging of Cancer with Nanoparticle-Based Theranostic Probes.

Authors:  Ying-Yu Ma; Ke-Tao Jin; Shi-Bing Wang; Hui-Ju Wang; Xiang-Min Tong; Dong-Sheng Huang; Xiao-Zhou Mou
Journal:  Contrast Media Mol Imaging       Date:  2017-06-19       Impact factor: 3.161

Review 10.  Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy.

Authors:  Morgan E Lorkowski; Prabhani U Atukorale; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Healthc Mater       Date:  2020-11-23       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.